- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Life Science & Biotech
Most of Indiana's largest public companies enjoyed strong 2012
June 15, 2013
Angie's List turned a profit for the first time in nearly two decades.
MoreLilly halts trial of experimental Alzheimers drug
June 14, 2013
The trial ended after participants showed abnormal liver biochemistry, the Indianapolis-based drugmaker said Thursday in a
statement.
MoreBio-Response expanding in Hendricks County
June 10, 2013
IBJ StaffWastewater equipment maker is moving to a Danville business park to build a $1.1 million facility.
MoreNew institute aims to attract 100 research scientists to Indiana
May 30, 2013
J.K. WallThe $360 million initiative will be formally launched on Thursday by Gov. Mike Pence, executives of five major life sciences
companies and officials of the state’s research universities.
MoreMobile health apps could cut into state companies' market share
May 18, 2013
J.K. WallThe future of Indiana’s sprawling health care and life sciences industry might be threatened by an unlikely source:
smartphone apps.
MorePINCUS: State needs better life sciences startup ecosystem
May 18, 2013
Jack Pincus / Special to IBJIndiana’s life sciences sector is mostly composed of legacy companies.
MoreReport: Roche mulls sale of blood-glucose monitor business
May 17, 2013
J.K. WallRoche Diagnostics Corp. is considering a sale of its blood-glucose meter business, a move that would cast uncertainty over
the nearly 1,000 people working for its diabetes business in Indianapolis.
MorePANEL: Life sciences will see radically different future
May 17, 2013
IBJ convened a panel of experts at its Life Sciences Power Breakfast on May 10 to talk about the industry issues
of venture capital, digital health innovations and research university entrepreneurship.
MorePanel members included Kristin Eilenberg, CEO, Lodestone Logic, Infuse Accelerator; Philip S. Low, Purdue University professor of chemistry, founder and chief science officer at Endocyte Inc. and On Target Laboratories LLC; R. Matthew Neff, president, CHV Capital Inc.; Brian Stemme, project director; BioCrossroads; Brian S. Williams, director, Global Healthcare Strategy, PricewaterhouseCoopers International Ltd.; and Raul Zaveleta, CEO, Indigo BioSystems Inc.
The following is an unedited transcript of the discussion.
New seed fund aims to make Indiana a hotbed for digital health startups
May 4, 2013
J.K. WallInfuse Accelerator hopes to make early-stage investments in 12 to 15 companies a year.
MoreLilly suing J&J for patent rights in Alzheimer's drug race
April 25, 2013
Bloomberg NewsEli Lilly and Co. is seeking to revoke a patent held by a Johnson & Johnson unit, arguing at a London court it might delay
availability of a potential treatment for Alzheimer’s disease.
MoreDow AgroSciences grows sales, earnings to new heights
April 25, 2013
Mason King, Bloomberg NewsRecord sales for seeds and new crop protection products helped boost revenue 14 percent at Indianapolis-based Dow AgroSciences
LLC in its new fiscal year.
MoreLilly seeks $30.6M in tax breaks on downtown projects
April 15, 2013
Mason KingIndianapolis development officials on Wednesday will weigh the 10-year requests from the pharmaceuticals giant related to
a new manufacturing plant and improvements to existing operations downtown.
MoreIU medical school's push to launch startups bears fruit
April 13, 2013
J.K. WallThe Indiana University School of Medicine has launched 12 companies in the past 18 months—a burst of startup activity
the school has never seen before.
MoreExpected revenue slump spurs Lilly to cut sales force
April 11, 2013
J.K. WallThe Indianapolis pharmaceuticals giant said Thursday that it would lay off hundreds of U.S. sales reps, as it prepares for
the loss of patent protection on two of its best-selling drugs.
MoreCity to buy key parcel for 16th Street tech corridor
April 6, 2013
Scott OlsonThe city of Indianapolis is poised to pay Citizens Energy Group $6.5 million to buy a key parcel of real estate it’s
targeting as the centerpiece of its ambitious 16 Tech project.
MoreLilly pulls back from proposals lowering takeover barriers
April 6, 2013
Greg AndrewsFortunately, a Lilly takeover looks less likely today than it has in a long time—for both obvious and more subtle reasons.
MoreLilly to spend $180M doubling size of Indy plant
April 2, 2013
The new investment will bring the plant's total price tag to $320 million as the pharmaceutical giant seeks to increase production
of insulin and related products.
MoreSherry Labs snapped up by Netherlands corporation
April 1, 2013
Jeff NewmanThe materials-testing business with nearly 300 employees has been acquired by Element Materials Technology. Sherry had been
owned by a group of well-connected central Indiana businessmen.
MoreProfits at center of biosimilars debate
March 18, 2013
J.K. WallHouse Bill 1315, which is scheduled for a Senate floor hearing on Monday, would require pharmacists to check with a patient’s
physician before automatically substituting a generic version of a biotech drug for a brand-name version.
MoreMedical device maker moving to Noblesville, adding jobs
March 12, 2013
Fishers-based Nexxt Spine LLC, a manufacturer of spinal implants, is consolidating operations and moving its headquarters
and manufacturing facility to Noblesville.
MoreQ&A
March 11, 2013
J.K. WallMike Sherman, the chief financial officer at West Lafayette-based Endocyte Inc., talked about how the drug
firm’s funding partnership with New Jersey-based Merck & Co. Inc. has helped accelerate development of the company’s
pipeline, which is branching out into drugs to treat cancers of the lung, prostate and breast.
MoreLilly sues Genentech to invalidate Erbitux-related patents
March 2, 2013
Bloomberg NewsEli Lilly and Co. has sued Roche Holding AG’s Genentech unit, asking a court to invalidate patents used to make treatments
for cancer and autoimmune diseases.
MoreDow AgroSciences wins bid to overturn pesticide guidelines
February 21, 2013
Bloomberg NewsIndianapolis-based Dow Agrosciences LLC and two other pesticide makers won a bid to overturn U.S. National Marine Fisheries
Service proposals to protect salmon when an appeals court found the agency’s decision “arbitrary and capricious.”
MoreLilly to expand partnership with diagnostic firm
February 14, 2013
IBJ Staff and Associated PressDiagnostic products maker Qiagen NV said Wednesday that it will work with Eli Lilly and Co. to develop new tests that could
identify patients who could be helped by Lilly's drugs.
More'12 worst year for life sciences since 1990s
February 11, 2013
J.K. WallTo understand why Indiana’s life sciences entrepreneurs are frustrated with the flow of venture capital, look no further
than this statistic from a recent PricewaterhouseCoopers report: 2012 was the slowest year for first-time life sciences investment
since 1995.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Thank you for pointing out the absurdity of having The Naked Cowboy at Zoobilation. For the life of me, I don’t know why anyone would want a picture with that guy, but there were plenty of folks lined up to get a shot with him. The event could have used more restrooms out on the bridge, more photo booths and vendors offering something besides meat. There were a few more veg-friendly options this year than last, but it has a long way to go.
Went to Zoobilation Friday night and had a great time. The weather was super nice and the food was very good, for the most part. Lots of sliders this year at many different tents. The slider from Alexander's was inedible, all four in my group ended up tossing it after one bite. Some tents were out of food by 8:30 and one bar area was out of cups at 8:30, not sure how that can happen. Great event in Indy and I look forward to it each year.
Many of the small community hospitals are now owned by the "cash-strapped" Indy biggies, with more coming. The doctor-practise buying has been done precisely to sidestep tiered payments for out-of-hospital procedures. These are no better done, or safer, because someone administers a pain shot or snaps an x-ray in a doctor's office. And the non-payment issue is resolved next year when we all have insurance, even though many still think paying private insurers an extra 10-20% is what makes our system "world-class".
I'd love to see this rendering put into the context of the surrounding neighborhood/area to get a better feel for the surrounding scale. However, just by the looks of it, it appears to be an excellent project. I'm pretty sure that if Scott Olson had said nothing regarding Chicago or Wrigleyville, Mr. "Horrible" would have found nothing bad to say. I'd love to know how Indy is becoming "Chicagofied"...
Truly great and funny play. Vocalists were Broadway caliber and stage settings ideal for small stage. Would go again!